Many high risk, high reward medical therapies that use cutting edge science are proving themselves in clinical trials. But are health services ready to pay for them—and how? Marianne Guenot reports On ...

Avascular necrosis in sickle cell disease can occur due to the impairment of blood supply to the bones, writes columnist.

In a series of recent legal challenges initiated by the pharmaceutical industry against the US Department of Health and Human Services Office of ...

Vertex Pharmaceuticals is diversifying from its cystic fibrosis dominance into pain and other markets. Check out our ...

Reshma is the kind of leader who can deliver that extraordinary future—it only seems crazy because no one’s done it before. I ...

Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with ...

Doctors and researchers at the University of Nebraska Medical Center are hoping to bring a different therapy that uses a ...

Kewalramani becme the first female CEO of a large, public U.S. biotechnology company after immigrating from India at age 11 ...

Reshma Kewalramani, the Indian-origin CEO of US-based Vertex Pharmaceuticals, has been named on the list of "100 Most ...

MONDAY, April 14, 2025 (HealthDay News) -- Women with sickle cell disease often have pain crises around the time of their ...

From US president Donald Trump to Tesla CEO Elon Musk, Time Magazine's 100 Most Influential People of 2025 list included some ...